Congo Wants More Use of Merck Vaccine Rather Than J&J Newcomer – Minister

Share this post

Democratic Republic of Congo called on Wednesday for Merck’s experimental Ebola vaccine to be fully licensed to facilitate its use in the Ebola-hit country, while saying Johnson & Johnson’s rival drug would complicate matters.
Reuters Health Information

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply